Genmab A GMAB
NASDAQ GMAB
$43.14 +3.14 (+7.85%)
As of: Oct 23, 2026 · 1:32 PM EDT

Genmab A (GMAB) Price to FCF (2025 - 2026)

Updated

Genmab A's (GMAB) Price to FCF came in at 1.39 for the quarter ended Jun 30, 2026, up 21.5% from the prior quarter.

Analysis

Genmab A (GMAB) Price to FCF (2025 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Genmab A's Price to FCF stood at 1.72, down 9.9% from the prior year.

  • Annual Price to FCF has declined for four consecutive years.
  • In prior years, Genmab A's Price to FCF was 1.91 in the year ended Dec 31, 2024 (-36.8%), 3.02 in the year ended Dec 31, 2023 (-60.6%), 7.66 in the year ended Dec 31, 2022 (-25.1%) and 10.23 in the year ended Dec 31, 2021 (+188.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.00 Bn 1,106.58 Bn 19.71 Bn
2 Johnson & Johnson 634.40 Bn 554.26 Bn 17.30 Bn
3 AbbVie 506.36 Bn 479.47 Bn 12.70 Bn
4 Merck 358.30 Bn 312.68 Bn 12.21 Bn
5 Novartis Ag 293.12 Bn 257.11 Bn 11.24 Bn
6 Astrazeneca 265.36 Bn 239.05 Bn 12.86 Bn
7 Amgen 238.40 Bn 193.80 Bn 7.24 Bn
8 Gilead Sciences 195.15 Bn 169.35 Bn 6.22 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn
10 Genmab A 2.78 Bn -2.59 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.01
Mar 31, 2026 1.53
Sep 30, 2025 1.51
API Access

Genmab A Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=GMAB&period=max&api_key=YOUR_API_KEY